GlassScriptPhysician profile
Warren Marc Ross
NPI 1770568891
$6,327.67
in general payments reported to CMS, 2019-2025
48 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,286 · 2020: $240 · 2021: $651 · 2022: $887 · 2023: $929 · 2024: $1,197 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,147 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,147.48 |
| Education | $117.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $673.97 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $583.46 | 2019-2025 | Qulipta |
| Amgen INC. | $576.18 | 2019-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $408.96 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Esperion Therapeutics, INC. | $360.36 | 2021-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $350.92 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $322.26 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $231.23 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Novartis Pharmaceuticals Corporation | $216.96 | 2023-2025 | |
| Astellas Pharma US INC | $208.46 | 2019-2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $203.23 | 2019-2024 | Xifaxan, Trulance |
| Harmony Biosciences LLC | $171.77 | 2020-2025 | |
| Allergan, INC. | $157.18 | 2019-2021 | |
| Amarin Pharma, INC. | $129.30 | 2019-2023 | |
| Idorsia Pharmaceuticals US INC | $128.87 | 2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.